FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹488 Cr | ₹550 Cr | ₹615 Cr | ₹730 Cr | ₹690 Cr |
What is the latest Total Current Liabilities ratio of FDC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹488 Cr |
| Mar2025 | ₹550 Cr |
| Mar2024 | ₹615 Cr |
| Mar2023 | ₹730 Cr |
| Mar2022 | ₹690 Cr |
How is Total Current Liabilities of FDC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹488 Cr | -11.37 | |
| Mar2025 | ₹550 Cr | -10.54 | |
| Mar2024 | ₹615 Cr | -15.68 | |
| Mar2023 | ₹730 Cr | 5.67 | |
| Mar2022 | ₹690 Cr | - | |
Compare Total Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,357.3 Cr | 0.1% | 15.5% | -7.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 0.1% |
15.5% |
-7.7% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses